ZA9410242B - Substituted 1-oxo-1,2-dihydrolsoquinolinoylguanidines and 1,1-dioxo-2H-1,2-benzothiazinoylguanidines a process for their preparation their use as a medicament or diagnostic agent and also a medicament containing them - Google Patents
Substituted 1-oxo-1,2-dihydrolsoquinolinoylguanidines and 1,1-dioxo-2H-1,2-benzothiazinoylguanidines a process for their preparation their use as a medicament or diagnostic agent and also a medicament containing themInfo
- Publication number
- ZA9410242B ZA9410242B ZA9410242A ZA9410242A ZA9410242B ZA 9410242 B ZA9410242 B ZA 9410242B ZA 9410242 A ZA9410242 A ZA 9410242A ZA 9410242 A ZA9410242 A ZA 9410242A ZA 9410242 B ZA9410242 B ZA 9410242B
- Authority
- ZA
- South Africa
- Prior art keywords
- medicament
- dihydrolsoquinolinoylguanidines
- benzothiazinoylguanidines
- dioxo
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Compression, Expansion, Code Conversion, And Decoders (AREA)
- Photoreceptors In Electrophotography (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4344550A DE4344550A1 (de) | 1993-12-24 | 1993-12-24 | Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9410242B true ZA9410242B (en) | 1995-08-02 |
Family
ID=6506276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9410242A ZA9410242B (en) | 1993-12-24 | 1994-12-22 | Substituted 1-oxo-1,2-dihydrolsoquinolinoylguanidines and 1,1-dioxo-2H-1,2-benzothiazinoylguanidines a process for their preparation their use as a medicament or diagnostic agent and also a medicament containing them |
Country Status (20)
Country | Link |
---|---|
US (1) | US5547953A (hu) |
EP (1) | EP0659748B1 (hu) |
JP (1) | JP3790559B2 (hu) |
KR (2) | KR100360127B1 (hu) |
CN (1) | CN1053899C (hu) |
AT (1) | ATE194605T1 (hu) |
AU (1) | AU683320B2 (hu) |
CA (1) | CA2138466A1 (hu) |
DE (2) | DE4344550A1 (hu) |
DK (1) | DK0659748T3 (hu) |
ES (1) | ES2149233T3 (hu) |
FI (1) | FI946039A (hu) |
GR (1) | GR3034335T3 (hu) |
HU (1) | HU222524B1 (hu) |
IL (1) | IL112114A (hu) |
NO (1) | NO304787B1 (hu) |
NZ (2) | NZ270264A (hu) |
PT (1) | PT659748E (hu) |
TW (1) | TW504505B (hu) |
ZA (1) | ZA9410242B (hu) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP0765867A1 (de) * | 1995-09-27 | 1997-04-02 | Hoechst Aktiengesellschaft | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament |
DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
DE19548708A1 (de) * | 1995-12-23 | 1997-06-26 | Merck Patent Gmbh | Cyclische Sulfone |
CA2195697A1 (en) * | 1996-02-02 | 1997-08-03 | Masahumi Kitano | Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof |
JPH10152481A (ja) * | 1996-09-25 | 1998-06-09 | Kanebo Ltd | ベンゾ[1,4]チアジン誘導体およびそれからなる医薬 |
EP0971908B1 (en) * | 1997-02-12 | 2004-06-30 | SmithKline Beecham Corporation | Il-8 receptor antagonists |
US6436927B1 (en) | 1997-02-12 | 2002-08-20 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
CA2283404A1 (en) | 1997-03-06 | 1998-09-11 | Jun Sasamori | Cycloalka¬b|pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same |
WO1998055475A1 (en) * | 1997-06-02 | 1998-12-10 | Fujisawa Pharmaceutical Co., Ltd. | Guanidine deriviatives as inhibitors of na+/h+ exchange in cells |
DE10163914A1 (de) * | 2001-12-22 | 2003-07-03 | Aventis Pharma Gmbh | Substituierte 4-Phenyltetrahydroisochinolinium-Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
US6703405B2 (en) | 2001-12-22 | 2004-03-09 | Aventis Pharma Deutschland Gmbh | Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as a medicament, and medicament containing them |
WO2006044645A2 (en) | 2004-10-13 | 2006-04-27 | Adolor Corporation | Sulfamoyl benzamides and methods of their use |
ES2639439T3 (es) | 2010-12-08 | 2017-10-26 | Lycera Corporation | Inhibidores de F1F0-ATPasas de tipo pirazolilguanidina y sus usos terapéuticos de éstos |
US9169199B2 (en) | 2010-12-08 | 2015-10-27 | Lycera Corporation | Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof |
WO2012078869A1 (en) | 2010-12-08 | 2012-06-14 | Lycera Corporation | Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
US9580391B2 (en) | 2012-06-08 | 2017-02-28 | Lycera Corporation | Saturated acyl guanidine for inhibition of F1F0-ATPase |
US9221814B2 (en) | 2012-06-08 | 2015-12-29 | Lycera Corporation | Heterocyclic guanidine F1F0-atpase inhibitors and therapeutic uses thereof |
US9920012B2 (en) | 2012-06-08 | 2018-03-20 | Lycera Corporation | Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof |
JP6486364B2 (ja) | 2013-12-10 | 2019-03-20 | リセラ・コーポレイションLycera Corporation | トリフルオロメチルピラゾリルグアニジンf1f0−atpアーゼ阻害剤及びその治療用途 |
CA2931850A1 (en) | 2013-12-10 | 2015-06-18 | Lycera Corporation | Alkylpyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
CA2931792A1 (en) | 2013-12-10 | 2015-06-18 | Lycera Corporation | N-substituted pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
EP0556674B1 (de) * | 1992-02-15 | 1996-06-19 | Hoechst Aktiengesellschaft | 3,5-Substituierte Benzoylguanidine, mit antiarrythmischer Wirkung und inhibierender Wirkung auf die Proliferationen von Zellen |
EP0589336B1 (de) * | 1992-09-22 | 1997-01-08 | Hoechst Aktiengesellschaft | Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika |
EP0590455B1 (en) * | 1992-09-28 | 2000-12-27 | Hoechst Aktiengesellschaft | Antiarrhythmic and cardioprotective substituted 1(2H)-isoquinolines, process for their production, medicament containing them and their use for the production of a medicament for combating heart failures |
TW250479B (hu) * | 1992-12-15 | 1995-07-01 | Hoechst Ag |
-
1993
- 1993-12-24 DE DE4344550A patent/DE4344550A1/de not_active Withdrawn
-
1994
- 1994-11-21 TW TW083110790A patent/TW504505B/zh not_active IP Right Cessation
- 1994-12-19 CA CA002138466A patent/CA2138466A1/en not_active Abandoned
- 1994-12-19 DE DE59409439T patent/DE59409439D1/de not_active Expired - Lifetime
- 1994-12-19 ES ES94120069T patent/ES2149233T3/es not_active Expired - Lifetime
- 1994-12-19 AT AT94120069T patent/ATE194605T1/de not_active IP Right Cessation
- 1994-12-19 EP EP94120069A patent/EP0659748B1/de not_active Expired - Lifetime
- 1994-12-19 PT PT94120069T patent/PT659748E/pt unknown
- 1994-12-19 DK DK94120069T patent/DK0659748T3/da active
- 1994-12-22 NZ NZ270264A patent/NZ270264A/en unknown
- 1994-12-22 NZ NZ272846A patent/NZ272846A/en unknown
- 1994-12-22 US US08/362,003 patent/US5547953A/en not_active Expired - Lifetime
- 1994-12-22 FI FI946039A patent/FI946039A/fi not_active Application Discontinuation
- 1994-12-22 IL IL11211494A patent/IL112114A/en not_active IP Right Cessation
- 1994-12-22 JP JP31959294A patent/JP3790559B2/ja not_active Expired - Fee Related
- 1994-12-22 CN CN94119193A patent/CN1053899C/zh not_active Expired - Fee Related
- 1994-12-22 ZA ZA9410242A patent/ZA9410242B/xx unknown
- 1994-12-22 HU HU9403759A patent/HU222524B1/hu not_active IP Right Cessation
- 1994-12-22 AU AU81700/94A patent/AU683320B2/en not_active Ceased
- 1994-12-23 NO NO944747A patent/NO304787B1/no unknown
- 1994-12-24 KR KR1019940036497A patent/KR100360127B1/ko not_active IP Right Cessation
-
2000
- 2000-09-06 GR GR20000402023T patent/GR3034335T3/el not_active IP Right Cessation
-
2002
- 2002-03-25 KR KR1020020016125A patent/KR100353339B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL112114A0 (en) | 1995-03-15 |
NO304787B1 (no) | 1999-02-15 |
TW504505B (en) | 2002-10-01 |
CN1053899C (zh) | 2000-06-28 |
ES2149233T3 (es) | 2000-11-01 |
KR100353339B1 (ko) | 2002-09-19 |
FI946039A (fi) | 1995-06-25 |
HU222524B1 (hu) | 2003-08-28 |
EP0659748B1 (de) | 2000-07-12 |
NZ270264A (en) | 1996-02-27 |
KR950017981A (ko) | 1995-07-22 |
NO945015D0 (no) | 1994-12-23 |
FI946039A0 (fi) | 1994-12-22 |
KR100360127B1 (ko) | 2003-04-23 |
JP3790559B2 (ja) | 2006-06-28 |
CN1107840A (zh) | 1995-09-06 |
NO945015L (no) | 1995-06-26 |
AU683320B2 (en) | 1997-11-06 |
IL112114A (en) | 2001-06-14 |
US5547953A (en) | 1996-08-20 |
DE4344550A1 (de) | 1995-06-29 |
DK0659748T3 (da) | 2000-10-02 |
NZ272846A (en) | 1996-02-27 |
CA2138466A1 (en) | 1995-06-25 |
EP0659748A1 (de) | 1995-06-28 |
AU8170094A (en) | 1995-06-29 |
HU9403759D0 (en) | 1995-02-28 |
HUT72749A (en) | 1996-05-28 |
DE59409439D1 (de) | 2000-08-17 |
GR3034335T3 (en) | 2000-12-29 |
PT659748E (pt) | 2000-11-30 |
ATE194605T1 (de) | 2000-07-15 |
JPH07206823A (ja) | 1995-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9410242B (en) | Substituted 1-oxo-1,2-dihydrolsoquinolinoylguanidines and 1,1-dioxo-2H-1,2-benzothiazinoylguanidines a process for their preparation their use as a medicament or diagnostic agent and also a medicament containing them | |
GR3024855T3 (en) | Substituted benzoylguanidines, process for their preparation, their use as medicament, as inhibitor of the cellular na+/h+ exchange or as diagnostic agent and medicament containing them. | |
NZ238181A (en) | N-(1-substituted-piperidinyl(alkyl))carbamic acid, urea and carboxamide derivatives and homologues thereof; preparatory processes and pharmaceutical compositions | |
NO934634L (no) | 3,5-substiturete aminobenzoylguanidiner, fremgangsmåte til fremstilling derav, deres anvendelse som medikament eller diagnostikum samt middel inneholdende forbindelsene | |
BR9503536A (pt) | Composto processo para sua preparação seu uso e composição farmacêutica | |
GB1535967A (en) | Antilipidemic para-(aryl(alkyl or alkenyl)-amino)-benzoic acid derivatives | |
CA2070663A1 (en) | Sulfonating agent and process | |
EP1122252A4 (en) | CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM | |
HU9601701D0 (en) | Aromatic hydroxamic acid compounds, process for producing them and their use | |
HUT71513A (en) | 2-substituted-(3-chlorophenyl)-3,6-diazahexanoic acid derivatives for producing alkil-trazodone derivatives and process for producing them | |
PH25158A (en) | Microbicidal agrochemical composition | |
IL114866A0 (en) | Process for the preparation of the (-)-n-methyl-n-Ú4-(4-phenyl-4-acetylaminopiperidin-1-yl-2-(3,4-dichlorophenyl) butyl¾ benzamide | |
JPS6485966A (en) | Benzoylurea-based compound, harmful animal controller containing said compound and production thereof | |
ES8405030A1 (es) | Un procedimiento para la preparacion de derivados de 3-amino-3-desmetoxifortimicina. | |
JPS54145615A (en) | Derivative of (1,3)-beta-d-glucane, its use and preparation | |
IT1236933B (it) | Procedimento per la preparazione di n-ciano-n'-metil-n"-(2-(((5-metil-1h-imidazol-4-il)metil)tio)etil)guanidina. |